Literature DB >> 20399950

Factors associated with contraceptive nonuse among US women ages 35-44 years at risk of unwanted pregnancy.

Kristen Upson1, Susan D Reed, Sarah W Prager, Melissa A Schiff.   

Abstract

BACKGROUND: Women ages 35 years and older have the greatest proportion of contraceptive nonuse and unintended pregnancies ending in abortion. STUDY
DESIGN: We conducted a population-based case-control study among women ages 35-44 years at risk of unwanted pregnancy using the National Survey of Family Growth (NSFG) data to investigate risk factors for contraceptive nonuse.
RESULTS: At last intercourse, 9.8% of women reported not using any contraceptive method. Contraceptive nonusers, as compared to users, were more likely to be ages 40-44 years (OR=2.0, 95% CI 1.1-3.7), foreign-born (OR=4.3, 95% CI 1.9-9.7), black (OR=2.8, 95% CI 1.1-7.0), with household incomes 100-249% of the federal poverty level (FPL) (OR=2.5, 95% CI 1.1-5.8). Women who received contraceptive counseling in the past year had an 80% decreased risk of nonuse (95% CI 0.1-0.5).
CONCLUSION: Public health strategies to reduce unintended pregnancy, particularly among women ages 35 years and older, should focus on addressing disparities in contraceptive use and promoting contraceptive counseling.

Entities:  

Mesh:

Year:  2010        PMID: 20399950     DOI: 10.1016/j.contraception.2009.12.013

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  15 in total

1.  Racial and ethnic disparities in contraceptive method choice in California.

Authors:  Grace Shih; Eric Vittinghoff; Jody Steinauer; Christine Dehlendorf
Journal:  Perspect Sex Reprod Health       Date:  2011-08-01

2.  Physician attitudes toward over the counter availability for oral contraceptives.

Authors:  David L Howard; Jeffrey Wall; Julie L Strickland
Journal:  Matern Child Health J       Date:  2013-12

3.  Racial and ethnic differences in contraceptive use among women who desire no future children, 2006-2010 National Survey of Family Growth.

Authors:  Cynthia D Grady; Christine Dehlendorf; Elan D Cohen; E Bimla Schwarz; Sonya Borrero
Journal:  Contraception       Date:  2015-04-09       Impact factor: 3.375

4.  Pregnancy preferences and contraceptive use among US women.

Authors:  Goleen Samari; Diana G Foster; Lauren J Ralph; Corinne H Rocca
Journal:  Contraception       Date:  2019-12-02       Impact factor: 3.375

5.  The impact of contraceptive counseling in primary care on contraceptive use.

Authors:  Jessica K Lee; Sara M Parisi; Aletha Y Akers; Sonya Borrero; Sonya Borrerro; Eleanor Bimla Schwarz
Journal:  J Gen Intern Med       Date:  2011-07       Impact factor: 5.128

6.  Early age at first intercourse and subsequent gaps in contraceptive use.

Authors:  Brianna M Magnusson; Saba W Masho; Kate L Lapane
Journal:  J Womens Health (Larchmt)       Date:  2011-10-12       Impact factor: 2.681

7.  Primary care physicians' perceptions of rates of unintended pregnancy.

Authors:  Sara M Parisi; Shannon Zikovich; Cynthia H Chuang; Mindy Sobota; Melissa Nothnagle; Eleanor Bimla Schwarz
Journal:  Contraception       Date:  2011-12-15       Impact factor: 3.375

8.  A checklist approach to caring for women seeking pregnancy testing: effects on contraceptive knowledge and use.

Authors:  Jessica Lee; Melissa Papic; Erin Baldauf; Glenn Updike; E Bimla Schwarz
Journal:  Contraception       Date:  2014-11-15       Impact factor: 3.375

9.  Counseling about medication-induced birth defects with clinical decision support in primary care.

Authors:  Eleanor Bimla Schwarz; Sara M Parisi; Steven M Handler; Gideon Koren; Grant Shevchik; Gary S Fischer
Journal:  J Womens Health (Larchmt)       Date:  2013-08-09       Impact factor: 2.681

10.  Sporadic contraceptive use and nonuse: age-specific prevalence and associated factors.

Authors:  Karen Pazol; Maura K Whiteman; Suzanne G Folger; Athena P Kourtis; Polly A Marchbanks; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2014-10-08       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.